Patients with tuberous sclerosis complex, a genetic disorder characterized by the growth of noncancerous tumors in multiple organs of the body, have limited treatment options. A team led by investigators at Massachusetts ...
Jan 9, 2021
0
124
While rare, botulism can cause paralysis and is potentially fatal. It is caused by nerve-damaging toxins produced by Clostridium botulinum—the most potent toxins known. These toxins are often found in contaminated food ...
Jan 8, 2021
0
47
A subcutaneous injection of the immune-boosting drug teclistamab was found to be safe and elicit responses in a majority of patients with relapsed or refractory multiple myeloma, according to findings from a multi-institutional ...
Dec 6, 2020
0
7
(HealthDay)—The U.S. Food and Drug Administration approved the first treatment for the rare genetic disorder primary hyperoxaluria type 1 (PH1), the agency announced Monday.
Nov 25, 2020
0
2
An injectable drug used to reduce stubbornly high cholesterol levels appears in animal studies to also enhance the immune response of anti-cancer therapies known as immune checkpoint inhibitors, a study led by Duke Health ...
Nov 12, 2020
0
143
An experimental antibody drug that targets one of the body's key metabolism regulators may help obese people lose weight—at least briefly.
Nov 3, 2020
0
38
Scientists have developed an injectable drug that blocks HIV from entering cells. They say the new drug potentially offers long-lasting protection from the infection with fewer side effects. The drug, which was tested in ...
Aug 21, 2020
1
293
The only antiviral drug currently used to treat SARS-CoV-2, the coronavirus that causes COVID-19, is remdesivir, but administering it is invasive and challenging. Scientists at The University of Texas at Austin are hoping ...
Jul 29, 2020
0
54
A safe haven in the U.S. where people can give themselves heroin and other drugs has observed more than 10,500 injections over five years and treated 33 overdoses with none proving fatal, researchers reported Wednesday.
Jul 9, 2020
0
0
(HealthDay)—Tauvid (flortaucipir F18), a radioactive diagnostic agent, was approved to image tau pathology in patients with cognitive impairment being evaluated for Alzheimer disease, the U.S. Food and Drug Administration ...
Jun 2, 2020
0
0
